Mesoblast (NASDAQ:MESO – Get Free Report) and Biogen (NASDAQ:BIIB – Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, analyst recommendations and risk. Risk & Volatility Mesoblast has a beta of 2.12, meaning […]

Biogen (NASDAQ:BIIB – Get Free Report) and NewAmsterdam Pharma (NASDAQ:NAMS – Get Free Report) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Profitability This table compares Biogen and NewAmsterdam Pharma’s net […]